Core Insights - Syra Health Corp. announced positive preliminary results from a clinical study of its mental health app, Syrenity, conducted by Indiana University [1][5] - The study involved 135 participants with moderate to severe depression, showing trends of reduced symptoms among users of the Syrenity app compared to non-users [2][4] Group 1: Clinical Study Details - The randomized study was led by Dr. Lorenzo-Luaces and included 63 users of Syrenity and 72 non-users [2] - Preliminary results indicated improvements in depression symptoms, overall well-being, cognitive reappraisal, and healthier emotional expression among Syrenity users [2][3] - A follow-up study will be conducted to assess the statistical significance of these findings and to analyze user engagement [3] Group 2: Participant Demographics - Approximately two-thirds of the study participants were women, with about 30% being racial-ethnic minorities [4] - Around 36% of participants had household incomes between 100,000, and 30% were unemployed at the time of the study [4] Group 3: Company Overview and Future Plans - Syra Health focuses on healthcare technology, particularly in behavioral and mental health, aiming to improve access and affordability [6] - The company plans to publish the study results in a scientific journal and offers Syrenity as a business-to-business product and for direct download on app stores [5][6] - Syrenity is designed to address multiple mental health challenges through evidence-based interventions and features an AI-driven companion for user engagement [7]
Syra Health Announces Positive Preliminary Results from Syrenity Study Led by Indiana University